Data from FDA - Curated by EPG Health - Last updated 27 July 2017

Indication(s)

To aid in the elimination of condylomata. Debride callous tissue. Apply to condyloma. Cover with suitable dressing for 5-6 days. Reapply as needed.

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Acute and Advanced Heart Failure

Acute and Advanced Heart Failure

What are the most effective treatments for acute heart failure? Can you define advanced heart failure? Discover here...

+ 3 more

Allergic Rhinitis

Allergic Rhinitis

Allergic rhinitis causes great strain on the workforce. Help to reduce sick days and improve productivity with appropriate treatment options.

+ 4 more

Anti-integrins in IBD

Anti-integrins in IBD

See presentations from a satellite symposium presented at UEG Week 2018, with a particular focus on rapid and sustained efficacy in IBD through biologics along with a need to utilise patient-empowered treatment models.

Load more

Related Content

More information

Category Value
Agency product number 5V2JDO056X
Orphan designation No
Product NDC 10481-3008
Date Last Revised 12-07-2010
Type HUMAN PRESCRIPTION DRUG
RXCUI 210710
Marketing authorisation holder Gordon Laboratories